Braun Stacey Associates’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Buy
33,057
+50
+0.2% +$25.3K 0.49% 76
2026
Q1
$16.4M Buy
33,007
+2,202
+7% +$1.04M 0.54% 75
2025
Q4
$13.1M Buy
30,805
+835
+3% +$358K 0.43% 80
2025
Q3
$14.2M Buy
29,970
+1,653
+6% +$783K 0.47% 82
2025
Q2
$13.3M Buy
28,317
+716
+3% +$327K 0.48% 80
2025
Q1
$12.9M Sell
27,601
-99
-0.4% -$44.6K 0.53% 73
2024
Q4
$11.6M Buy
27,700
+10
+0% +$4.56K 0.43% 79
2024
Q3
$13.2M Buy
27,690
+238
+0.9% +$109K 0.5% 74
2024
Q2
$12M Buy
27,452
+2,224
+9% +$979K 0.47% 77
2024
Q1
$11.7M Sell
25,228
-21
-0.1% -$9.09K 0.46% 82
2023
Q4
$10.4M Buy
25,249
+6,782
+37% +$2.67M 0.46% 83
2023
Q3
$6.88M Buy
+18,467
New +$7.03M 0.33% 87

Other funds holding LIN

Braun Stacey Associates's LIN Position: Q2 2026 in Review

Braun Stacey Associates increased its Linde (LIN) stake by 0.15% in Q2 2026, buying an estimated $25.3K and bringing the position to 33,057 shares worth $17.2M. The position accounts for 0.49% of the portfolio, ranked #76.

Braun Stacey Associates first reported a position in LIN in Q3 2023 and has held it in 12 quarters since. 2,341 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • Braun Stacey Associates held 33,057 shares of Linde worth $17.2M as of Q2 2026.
  • Braun Stacey Associates bought 50 Linde shares in Q2 2026, an estimated $25.3K.
  • Linde made up 0.49% of Braun Stacey Associates's portfolio in Q2 2026, its #76 holding.
  • Braun Stacey Associates first reported a position in Linde in Q3 2023 and has held it in 12 quarters since.
  • 2,341 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Braun Stacey Associates's 13F filing for Q2 2026, filed 5 Aug 2026.